According to FutureWise analysis, the market for cell-based assays in 2025 is US$19.8 billion, and is expected to reach US$37.93 billion by 2033 at a CAGR of 8.60%. The Cell-Based Assay Market landscape is diverse, encompassing various end-users, including academic and government institutions, contract research organizations (CROs), and pharmaceutical and biotechnology...

According to FutureWise analysis, the market for Cell Analysis in 2023 is US$19.9 billion, and is expected to reach US$37.17 billion by 2031 at a CAGR of 8.10%. The Cell Analysis Market is on an exciting upward trajectory, projected to soar from approximately USD 19.9 billion in 2023 to a staggering USD 37.17 billion by 2031. With a robust compound annual growth rate (CAGR) of 8.1%, this...

According to FutureWise analysis, the market for celiac disease drugs in 2023 is US$0.88 billion, and is expected to reach US$2.03 billion by 2031 at a CAGR of 11.10%. The global Celiac Disease Drugs Market was valued at approximately USD 0.88 billion in 2023 and is projected to grow significantly, reaching USD 2.03 billion by 2031. This remarkable growth trajectory represents a compound annual...

According to FutureWise analysis, the market for celiac disease drugs in 2023 is US$0.88 billion, and is expected to reach US$2.03 billion by 2031 at a CAGR of 11.10%. The global Celiac Disease Drugs Market was valued at approximately USD 0.88 billion in 2023 and is projected to grow significantly, reaching USD 2.03 billion by 2031. This remarkable growth trajectory represents a compound annual...

The synthesis of complementary DNA (cDNA) opens up a world of exciting opportunities in bioinformatics and genetics! cDNA, which is double-stranded DNA created from a single strand of RNA, is a powerful tool primarily used to clone eukaryotic genes into prokaryotic systems. When a cell fails to produce a specific protein, we can effectively transfer cDNA into the donor cell, enabling it to...

According to FutureWise analysis the market for bariatric surgery in 2023 is US$ 1.88 billion, and is expected to reach US$ 3.18 billion by 2031 at a CAGR of 6.80%. The global bariatric surgery market is on an upward trajectory, currently valued at around $1.88 billion in 2023 and projected to reach approximately $3.18 billion by 2031. This impressive growth, at a compound annual growth rate...

According to FutureWise analysis the market for bacteriostatic water for injection is expected to register a CAGR of 6.82% from 2025-2033. Bacteriostatic water is a crucial component in the pharmaceutical industry, characterized by a unique composition that includes 0.9% benzyl alcohol. This sterile solution is a vital tool for breaking down powdered medications, making it indispensable for...

According to FutureWise analysis the market for Bacteriophage Therapy in 2023 is US$ 45.1 million, and is expected to reach US$ 74.2 million by 2031 at a CAGR of 6.4%. The global bacteriophage therapy market is experiencing significant growth. Valued at about $45 million in 2023, it’s projected to surge to nearly $74 million by 2031, marking a robust compound annual growth rate (CAGR) of...

According to FutureWise analysis the market for Baby Vitamin D Drops in 2023 is US$ 1.46 billion, and is expected to reach US$ 2.46 billion by 2031 at a CAGR of 6.80%. The global market for Baby Vitamin D Drops is on a remarkable trajectory, valued at around $1.46 billion in 2023 and projected to soar to approximately $2.46 billion by 2031. This impressive growth, with a compound...

According to FutureWise analysis the market for Baby Incubator is expected to register a CAGR of 7.12% from 2025-2033. The global baby incubator market is poised for significant growth, projected to achieve a compound annual growth rate (CAGR) of around 7.12% from 2024 to 2032. This robust expansion can be attributed to several key factors. Firstly, the increasing prevalence of premature births...